Brodalumab in the treatment of psoriatic arthritis – the latest reports

Código QR

Brodalumab in the treatment of psoriatic arthritis – the latest reports

Guardado en:

Detalles Bibliográficos
Autor principal:	Katarzyna Banaszczyk
Formato:	article
Lenguaje:	EN
Publicado:	Termedia Publishing House 2021
Materias:	Medicine R
Acceso en línea:	https://doaj.org/article/a029196b379448e4b0bb3295d42dbcd4
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

An Update for the Clinician on Biologics for the Treatment of Psoriatic Arthritis
por: Chimenti MS, et al.
Publicado: (2020)

Prevalence of Psoriatic Arthritis among Psoriatic Patients in Damietta Governorate
por: Aisha Mohamed, et al.
Publicado: (2019)

Long term efficacy and safety of etanercept in the treatment of psoriasis and psoriatic arthritis
por: Kivelevitch D, et al.
Publicado: (2014)

Editorial: Early Origins of Psoriatic Arthritis
por: David Simon, et al.
Publicado: (2021)

Association of Behçet disease with psoriasis and psoriatic arthritis
por: Hyung Jin Hahn, et al.
Publicado: (2021)

The Digital Way to Intercept Psoriatic Arthritis
por: Ivan Giovannini, et al.
Publicado: (2021)

Risk factors associated with osteoporosis and fracture in psoriatic arthritis
por: Yu Wang, et al.
Publicado: (2021)

Psoriasis to Psoriatic Arthritis: The Application of Proteomics Technologies
por: Fei Qi, et al.
Publicado: (2021)

Abatacept for the treatment of adults with psoriatic arthritis: patient selection and perspectives
por: Noisette A, et al.
Publicado: (2018)

Profile of ustekinumab and its potential in the treatment of active psoriatic arthritis
por: Montepaone M, et al.
Publicado: (2014)

Update on the treatment of psoriasis and psoriatic arthritis – role of apremilast
por: Forchhammer S, et al.
Publicado: (2015)

Clinical potential of brodalumab in the management of psoriasis: the evidence to date
por: Sandoval LF, et al.
Publicado: (2015)

Serum lipid metabolism in psoriasis and psoriatic arthritis – an update
por: Aldona Pietrzak, et al.
Publicado: (2019)

A Successful Treatment of Ostraceous Psoriasis Associated with Psoriatic Arthritis in Children: A Case Report
por: Rowawi R, et al.
Publicado: (2020)

Quality of life in patients with psoriatic arthritis
por: Kseniya Mikhailovna Koreshkova, et al.
Publicado: (2021)

IMMUNE PATHOGENESIS OF PSORIASIS AND PSORIATIC ARTHRITIS
por: S. V. Smirnova, et al.
Publicado: (2014)

Anti-tumor necrosis factor (TNF) drugs for the treatment of psoriatic arthritis: an indirect comparison meta-analysis
por: Thorlund K, et al.
Publicado: (2012)

Reappraisal of the clinical use of leflunomide in rheumatoid arthritis and psoriatic arthritis
por: Peter BB Jones, et al.
Publicado: (2010)

Perceptions of Rheumatologists on Diagnosis of Psoriatic Arthritis in China
por: Miao Chen, et al.
Publicado: (2021)

Optimal management of dactylitis in patients with psoriatic arthritis
por: Yamamoto T
Publicado: (2015)

Biomarkers of subclinical atherosclerosis in patients with psoriatic arthritis
por: Peluso R, et al.
Publicado: (2019)

Ustekinumab-induced chronic lymphocytic leukemia in a patient with psoriatic arthritis
por: Fusun Gediz, et al.
Publicado: (2021)

GENETIC FACTORS IN IMMUNOPATHOGENESIS OF PSORIASIS AND PSORIATIC ARTHRITIS
por: M. V. Smolnikova, et al.
Publicado: (2014)

Anti-tumor necrosis factor (TNF) drugs for the treatment of psoriatic arthritis: an indirect comparison meta-analysis [Corrigendum]
por: Thorlund K, et al.
Publicado: (2014)

Skin expression of IL-23 drives the development of psoriasis and psoriatic arthritis in mice
por: Lili Chen, et al.
Publicado: (2020)

Rho-GTPase pathways may differentiate treatment response to TNF-alpha and IL-17A inhibitors in psoriatic arthritis
por: Sara Rahmati, et al.
Publicado: (2020)

Elevated serum Dickkopf-1 is a biomarker for bone erosion in patients with psoriatic arthritis
por: Yukchiu Chung, et al.
Publicado: (2021)

An evidence-based review of certolizumab pegol in the treatment of active psoriatic arthritis: place in therapy
por: Acosta-Felquer ML, et al.
Publicado: (2016)

Brazilian Society of Rheumatology 2020 guidelines for psoriatic arthritis
por: Sueli Carneiro, et al.
Publicado: (2021)

Local effects of adipose tissue in psoriasis and psoriatic arthritis
por: Kruglikov IL, et al.
Publicado: (2017)

Psoriasis epidemiology screening tool (PEST) is useful for the detection of psoriatic arthritis in the Japanese population
por: Ayako Setoyama, et al.
Publicado: (2021)

Search for genetic markers of predisposition to psoriasis and psoriatic arthritis
por: M. V. Smolnikova, et al.
Publicado: (2020)

AGE-DEPENDENT INDEXES OF IMMUNITY IN THE PATIENTS WITH PSORIATIC ARTHRITIS
por: A. A. Barilo, et al.
Publicado: (2019)

Methotrexate-Related Liver Cirrhosis in Psoriatic Arthritis: A Case Report and Review of the Literature
por: Maria-Loukia Koutsompina, et al.
Publicado: (2021)

Efficacy and safety of secukinumab over 52 weeks in Chinese psoriasis patients with concomitant psoriatic arthritis
por: Lin Cai, et al.
Publicado: (2021)

Treatment with Ixekizumab Following Secukinumab Failure in Patients with Psoriatic Arthritis: Real-Life Experience from a Resistant Population
por: Berman J, et al.
Publicado: (2021)

Validity and reliability of the Dutch adaptation of the Psoriatic Arthritis Quality of Life (PsAQoL) Questionnaire.
por: Freke Wink, et al.
Publicado: (2013)

Gene Expression Profiling of Monozygotic Twins Affected by Psoriatic Arthritis
por: Angioni MM, et al.
Publicado: (2021)

Tofacitinib in the management of active psoriatic arthritis: patient selection and perspectives
por: Ly K, et al.
Publicado: (2019)

RECOMMENDATIONS FOR THE TREATMENT OF ACNE, SUMMARISED ACCORDING TO THE LATEST INTERNATIONAL GUIDELINES
por: Manca Valjavec, et al.
Publicado: (2021)